Neocare (Tretinoin)

Tretinoin, the active ingredient in Neocare, is a retinoid presented as a topical formulation for skin application. It is prescribed for the treatment of acne vulgaris, photodamage and hyperkeratotic skin conditions in adult patients.

GNH USA supplies Neocare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution.

Neocare (tretinoin) is a topical retinoid that modulates epidermal cell turnover in several dermatologic conditions.

Acne vulgaris: reduces comedones and inflammatory lesions by normalizing follicular epithelial desquamation. Photodamage: improves fine lines, mottled pigmentation and texture by promoting collagen synthesis and epidermal renewal. Hyperkeratosis: softens and thins hyperkeratotic plaques through accelerated keratinocyte differentiation.

Tretinoin may cause a range of local skin reactions, varying from mild irritation to rare severe events.

Common Side Effects: - Erythema or redness of the treated area. - Dryness and peeling of the skin. - Itching or mild burning sensation. - Increased sensitivity to sunlight. - Flaking or scaling. - Transient worsening of acne during initial use.

Serious or Rare Side Effects: - Severe dermatitis or blistering. - Urticaria or angioedema. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Exfoliative dermatitis. - Persistent severe photosensitivity. - Secondary bacterial or fungal infection of irritated skin.

When prescribing Neocare, clinicians should observe several precautionary measures to minimize risk.

Pregnancy: avoid use; potential teratogenic risk. Breastfeeding: discontinue if nursing; limited safety data. Sun exposure: limit UV exposure and use broad‑spectrum sunscreen. Concurrent topical irritants: avoid using other exfoliating agents simultaneously. Skin integrity: do not apply to compromised or inflamed skin. Store at below 25°C: keep in original container, protect from moisture and light.

Tretinoin can interact with other topical or systemic agents, altering its efficacy or safety profile.

Major Interactions (Avoid): - Systemic retinoids (e.g., isotretinoin): increased risk of severe skin irritation. - Enzyme inducers such as phenobarbital: may reduce tretinoin effectiveness. - Photosensitizing drugs (e.g., tetracyclines): amplify photosensitivity.

Moderate Interactions (Monitor Closely): - Benzoyl peroxide: may cause increased irritation; consider staggered application. - Alpha‑hydroxy acids or salicylic acid: monitor for excessive dryness. - Topical corticosteroids: may diminish tretinoin activity; adjust regimen as needed.